Investment Profile

Lucerne emphatically believes we will only acquire firms that we believe are reasonably priced. We identify firms for which we can acquire a controlling interest in a select number of established companies that can attain superior returns over a long-term investment horizon. By Lucerne selecting only those acquisition targets with stable cash flows, management expertise and proven operational history we will be able to provide superior risk adjusted returns.  

Industry: Broad industry focus in the following general market segments
  • Healthcare- including pharmaceutical, distribution, medical products
  • Real estate
  • Automotive
  • Distribution
  • Service Businesses
Lucerne does not typically invest in retail businesses, restaurants or heavy manufacturing

Industry Position:
Sustainable competitive advantage in stable or growth industries with proprietary products/brands, patents or industry niches.

Growth Outlook:
Anticipated company revenue growth no less than 10% with the ideal target in the mid to upper teens in a growing market segment

Size: Firms that are generating between $500,000 to $5,000,000 in EBITDA; EBITDA margins of >15%: Gross Margins >20%

Ownership:
Controlling Interest. Lucerne invests in (i) growth capital opportunities (ii) generational changes (family related transitional events) (iii) restructuring (iiii) recapitalization

Valuation:
Based upon trailing 12-24 months EBITDA

Investment Size: Lucerne typically likes to make initial investments between $500,000 and $10,000,000 and to provide additional capital for growth.

 

Contact Us

Lucerne

560 E. Town Street
Columbus, OH 43215
o: 614.486.5311
f:  614.568.7540
info@lucernecorp.com